US2005044588A1PendingUtilityA1
Methods and substances for preventing and treating autoimmune disease
Priority: Oct 7, 1997Filed: Aug 17, 2004Published: Feb 24, 2005
Est. expiryOct 7, 2017(expired)· nominal 20-yr term from priority
A61K 39/00C12N 9/88A61K 48/00C07K 14/28C12N 15/8258C07K 2319/00C07K 14/62C12N 15/8216
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A plant-based edible vaccine against autoimmune disease prepared by expressing a CTB-autoantigen chimeric gene construct in plant cells and transgenic plants is disclosed. DNA constructs, expression vectors comprising a nucleotide sequence that encodes a CTB-autoantigen chimeric gene, which are optimized for expression in plants, are described.
Claims
exact text as granted — not AI-modified1 . A polynucleotide comprising a cholera toxin coding sequence and two or more than two different mammalian autoantigen coding sequences.
2 . A plant cell transformed with the polynucleotide according to claim 1; where the polynucleotide further comprises at least one promoter for expression in a plant cell.
3 . A transgenic plant transformed with the polynucleotide according to claim 1; where the polynucleotide further comprises at least one promoter for expression in a plant cell.
4 . A method for preparing an autoantigen in a plant cell comprising:
growing plant cells transformed with the polynucleotide according to claim 1; where the polynucleotide further comprises at least one promoter for expression in a plant cell.
5 . A method for preparing an autoantigen in a transgenic plant comprising:
transforming a plant with the polynucleotide according to claim 1 , where the polynucleotide further comprises at least one promoter for expression in a plant cell; and allowing the plant to express the autoantigen.
6 . A vector comprising the polynucleotide according to claim 1 .
7 . The vector of claim 6 , where the polynucleotide further comprises at least one promoter for expression in a plant cell.
8 . The polynucleotide according to claim 1 , where at least one of the two different autoantigens encoded by the autoantigen coding sequences is glutamic acid decarboxylase.
9 . The polynucleotide according to claim 1 , where at least one of the two different autoantigens encoded by the autoantigen coding sequences is insulin.
10 . The polynucleotide according to claim 1 , where at least one of the two different autoantigens encoded by the autoantigen coding sequences comprises at least two epitopes.
11 . A polynucleotide comprising a cholera toxin coding sequence and two or more than two copies of the same mammalian autoantigen coding sequences;
where the autoantigen acts to downregulate at least part of the immune system of the mammal that is responsible for causing the autoimmune disease.
12 . A plant cell transformed with the polynucleotide according to claim 11; where the polynucleotide further comprises at least one promoter for expression in a plant cell.
13 . A transgenic plant transformed with the polynucleotide according to claim 11; where the polynucleotide further comprises at least one promoter for expression in a plant cell.
14 . A method for preparing an autoantigen in a plant cell comprising:
growing plant cells transformed with the polynucleotide according to claim 11; where the polynucleotide further comprises at least one promoter for expression in a plant cell.
15 . A method for preparing an autoantigen in a transgenic plant comprising:
transforming a plant with the polynucleotide according to claim 11 , where the polynucleotide further comprises at least one promoter for expression in a plant cell; and allowing the plant to express the autoantigen.
16 . A vector comprising the polynucleotide according to claim 11 .
17 . The vector of claim 16 , where the polynucleotide further comprises at least one promoter for expression in a plant cell.
18 . The polynucleotide according to claim 11 , where the autoantigen encoded by the autoantigen coding sequence is glutamic acid decarboxylase.
19 . The polynucleotide according to claim 11 , where the autoantigen encoded by the autoantigen coding sequence is insulin.
20 . The polynucleotide according to claim 11 , where the autoantigen encoded by the autoantigen coding sequence comprises at least two epitopes.Join the waitlist — get patent alerts
Track US2005044588A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.